Capital expenditures were $27 million in the fourth quarter of 2024, compared to $38 million in the fourth quarter of 2023. Revenue was $2,737 million in 2024, a decrease of 7% on a reported basis and ...

Rivian reported strong fourth quarter results after the bell on Thursday and came through on its goal of posting a "gross profit" for the quarter, with a smaller than expected full-year 2024 EBITDA ...

Q4 2024 Earnings Call February 20, 2025 8:30 AM ETCompany ParticipantsKarin Daly - VP, The Equity GroupKevin Burke ...

Anglo American posted an annual loss of $3.1 billion on Thursday after taking an impairment of $3.8 billion, mostly due to ...

Materialise NV (NASDAQ:MTLS), a leading provider of additive manufacturing and medical software solutions and of ...

Pulmonx Corporation (Nasdaq: LUNG) ("Pulmonx" or the "Company"), a global leader in minimally invasive treatments for lung disease, today reported ...

Financing outstandings have strongly increased in 2024 due to the increase of business and to the sharp rise in average ...

During the fourth quarter, Outset Medical made significant progress. Gross margin, essential for profitability, improved dramatically. It reached 37.7%, reflecting operational efficiencies compared to ...